Search results (3)
« Back to NewsScientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
16 December 2022
Department Immunology Research
New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Department of Oncology to collaborate with Crescendo Biologics
20 September 2019
Department Immunology Research
The Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
Study suggests immune system plays key role in survival after pancreatic cancer surgery
12 February 2019
Researchers in Oxford have found that an individual’s immune system – and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer.